Message to Members

Dear Member,

Curi is a mission-driven company. When we’re evaluating our performance, the first question we ask is if we have advanced our mission of helping physicians in medicine, business, and life. And we’re pleased to report that across the financial, strategic, and operational elements of our performance, the answer for 2021 is a resounding Yes.

We advanced our members’ financial interest in a meaningful way, growing your value as owners of the business by nearly 16%—by that measure, the strongest year the company has ever seen. With $1.3 billion in total assets under control, we have a strong foundation to support your financial interests not only now, but also well into the future.

Strategically, we took several significant steps to increase the ways the company can help you and your practices manage the disruptions of our industry. 2021 was the year when we definitively reshaped the company into three distinct business units, each focused on supporting different elements of your practice: Curi Advisory, Curi Capital, and Curi Insurance. Our newest business unit, Curi Advisory, was bolstered by our acquisition of the healthcare data analytics and advisory firm Arrowlytics, which brought their tools, consulting services, and team of seasoned experts into the Curi fold. We also continued our geographic expansion across the enterprise, adding team members and capabilities in states such as Georgia, Ohio, and Texas.

On the operational front, we made substantial progress in building and enhancing the talent, systems, and processes that keep us running smoothly to deliver strong results for you. We strengthened our telework capabilities during the second year of the COVID-19 pandemic, hitting our business plan goals while the bulk of our workforce continued to be situated outside of our physical offices. We also successfully recruited and onboarded more than 30 new professionals (not counting our new Arrowlytics colleagues), increased the power and flexibility of our technology ecosystem, and significantly built out our capabilities in innovation and business intelligence.

It’s our pleasure to share the details about how we delivered on our mission to serve you in 2021, and an even greater pleasure to be able to serve you in the first place. Thank you for your trust in Curi.

Sincerely,

A. Dale Jenkins

Jason Sandner
Chief Executive Officer

Robert E. Schaaf, MD

Robert E. Schaaf, MD
Chairman


Board of Directors

Robert E. Schaaf, MD
Chairman and President
Radiology
Raleigh, NC
Martha Chesnutt, MD
Internal Medicine
Rocky Mount, NC
Michael P. Moulton, MD
Emergency Medicine
Wilmington, NC
Chris M. Teigland, MD
Vice Chairman and First Vice President
Urology
Charlotte, NC
E. Hunter Dyer, MD
Neurosurgery
Charlotte, NC
Scott Shapiro, MD
Cardiology
Abington, PA
A. Dale Jenkins
Retired Chief Executive Officer
Raleigh, NC
Jeffrey Forman, MD
Pulmonology
Suffolk, VA
Caroline Wilds, MD
Internal Medicine
Charlotte, NC
Robert E. Schaaf, MD
Chairman and President
Radiology
Raleigh, NC
Chris M. Teigland, MD
Vice Chairman and First Vice President
Urology
Charlotte, NC
A. Dale Jenkins
Retired Chief Executive Officer
Raleigh, NC
Martha Chesnutt, MD
Internal Medicine
Rocky Mount, NC
E. Hunter Dyer, MD
Neurosurgery
Charlotte, NC
Jeffrey Forman, MD
Pulmonology
Suffolk, VA
Michael P. Moulton, MD
Emergency Medicine
Wilmington, NC
Scott Shapiro, MD
Cardiology
Abington, PA
Caroline Wilds, MD
Internal Medicine
Charlotte, NC
Curi Holdings